发明名称 |
ACF DETECTION METHOD |
摘要 |
The present invention provides a method for detecting ACF by analyzing a test region of large intestine tissue at the molecular level. Namely, the present invention relates to a method for detecting aberrant crypt foci (ACF) that comprises detecting an ACF detection marker in a test region of large intestine tissue, by using one or more types of molecules for which ACF-specific expression increases as the ACF detection marker, the molecule being selected from the group consisting of SLC2a1, and SLC7a7; an ACF detection marker for detecting the ACF in human-derived large intestine tissue, that is SLC2a1, or SLC7a7; and, a method for evaluating risk of colorectal cancer and colorectal adenoma in subjects based on the results of detecting ACF in a test region of large intestine tissue of the subjects using the aforementioned ACF detection method. |
申请公布号 |
US2014287412(A1) |
申请公布日期 |
2014.09.25 |
申请号 |
US201414297872 |
申请日期 |
2014.06.06 |
申请人 |
OLYMPUS CORPORATION ;THE UNIVERSITY OF TOKUSHIMA |
发明人 |
Ono Fumiko;Horino Yoko;Takayama Tetsuji;Muguruma Naoki;Okamoto Koichi |
分类号 |
G01N33/574;A61B5/00 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for detecting aberrant crypt foci (ACF), comprising:
detecting one or more types of molecules for which ACF-specific expression increases, and selected from the group consisting of SLC2a1 and SLC7a7 as an ACF detection marker, in a test region of large intestine tissue of an animal. |
地址 |
Tokyo JP |